Ad is loading...
VIVAX
Price
$68.72
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
VWNAX
Price
$87.57
Change
-$0.95 (-1.07%)
Updated
Nov 15 closing price
Ad is loading...

VIVAX vs VWNAX

Header iconVIVAX vs VWNAX Comparison
Open Charts VIVAX vs VWNAXBanner chart's image
Vanguard Value Index I
Price$68.72
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
Vanguard Windsor™ II Admiral™
Price$87.57
Change-$0.95 (-1.07%)
VolumeN/A
CapitalizationN/A
VIVAX vs VWNAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VIVAX vs. VWNAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIVAX is a StrongSell and VWNAX is a Buy.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. VWNAX (61.1B). VIVAX pays higher dividends than VWNAX: VIVAX (2.25) vs VWNAX (1.53). VIVAX was incepted earlier than VWNAX: VIVAX (32 years) vs VWNAX (24 years). VWNAX is a more actively managed with annual turnover of: 17.00 vs. VIVAX (10.00). VIVAX has a lower initial minimum investment than VWNAX: VIVAX (3000) vs VWNAX (50000). VIVAX annual gain was more profitable for investors over the last year : 25.55 vs. VWNAX (18.43). VIVAX return over 5 years is better than : 50.81 vs. VWNAX (27.63).
VIVAXVWNAXVIVAX / VWNAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years24 years-
Gain YTD17.91215.133118%
Front LoadN/AN/A-
Min. Initial Investment3000500006%
Min. Initial Investment IRAN/AN/A-
Net Assets184B61.1B301%
Annual Yield % from dividends2.251.53147%
Returns for 1 year25.5518.43139%
Returns for 3 years21.58-0.19-11,136%
Returns for 5 years50.8127.63184%
Returns for 10 years110.4623.37473%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LI22.720.49
+2.20%
Li Auto
ICCC3.610.01
+0.28%
ImmuCell Corp
BXC120.39-0.95
-0.78%
BlueLinx Holdings
LNTH76.83-4.01
-4.96%
Lantheus Holdings
PSTX2.76-0.45
-14.02%
Poseida Therapeutics